Liver: Macular Degeneration may help to treat exudative age related macular degeneration (AMD) and other ocular neovascular diseases by reducing choroidal neovascularization and hemorrhage. Best taken in powder form, it functions as a anti-angiogenic and anti-inflammatory agent by regulating VEGF, may help to preserve vision and slow disease progression. 
 
Used to treat exudative AMD, pathological myopia, and central exudative chorioretinitis by reducing CNV (choroidal neovascularization) and hemorrhage. Acts similarly to anti-VEGF drugs like ranibizumab by inhibiting VEGF expression, though through different, multi-target pathways. Commonly prepared as a a water based tea for oral consumption. Improvements may be seen in visual acuity and decreased central macular thickness (CMT) in patients.
 
Contains 100g dried, 100g powder, 200 tablets or 200 capsules. Please state when ordering which format you would like. BEST TAKEN IN POWDER. Should be used under the guidance of a qualified TICM practitioner, particularly for chronic eye diseases.